Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 15

1.

What are editors for?

Burch D, Mafham M, Yudkin JS.

Lancet. 2012 Jun 16;379(9833):2240. doi: 10.1016/S0140-6736(12)60977-5. No abstract available.

PMID:
22704168
2.

Insulin degludec and insulin degludec/insulin aspart: a review of their use in the management of diabetes mellitus.

Keating GM.

Drugs. 2013 May;73(6):575-93. doi: 10.1007/s40265-013-0051-1. Review.

PMID:
23620200
3.

Intensifying insulin therapy with insulin analog premixes: transitioning from basal insulin in type 2 diabetes.

Shanik MH.

Diabetes Technol Ther. 2012 Jun;14(6):533-9. doi: 10.1089/dia.2011.0256. Epub 2012 Feb 24. Review.

PMID:
22364142
4.

A comparison of biphasic insulin aspart and insulin glargine administered with oral antidiabetic drugs in type 2 diabetes mellitus--a systematic review and meta-analysis.

Rys P, Wojciechowski P, Siejka S, Małecki P, Hak L, Malecki MT.

Int J Clin Pract. 2014 Mar;68(3):304-13. doi: 10.1111/ijcp.12337. Epub 2014 Jan 28. Review.

PMID:
24471814
5.

Clinical use of the co-formulation of insulin degludec and insulin aspart.

Kumar A, Awata T, Bain SC, Ceriello A, Fulcher GR, Unnikrishnan AG, Arechavaleta R, Gonzalez-Gálvez G, Hirose T, Home PD, Kaku K, Litwak L, Madsbad S, Pinget M, Mehta R, Mithal A, Tambascia M, Tibaldi J, Christiansen JS.

Int J Clin Pract. 2016 Aug;70(8):657-67. doi: 10.1111/ijcp.12821. Epub 2016 Jul 7. Review.

PMID:
27384031
6.

Biphasic insulin aspart 30 for the treatment of type 1 diabetes mellitus.

Velásquez-Mieyer PA, Neira CP.

Expert Opin Pharmacother. 2008 Sep;9(13):2377-82. doi: 10.1517/14656566.9.13.2377 . Review.

PMID:
18710361
7.

Insulin glargine clinical trials.

White JR Jr.

Clin Ther. 2004 Jul;26(7):1179-81; discussion 1182-3. Review. No abstract available.

PMID:
15336483
8.

Insulin aspart in diabetic pregnancy: state of the art.

Mathiesen ER.

Womens Health (Lond). 2008 Mar;4(2):119-24. doi: 10.2217/17455057.4.2.119. Review.

PMID:
19072511
9.

[An update on multiple insulin injection therapy in type 1 and 2 diabetes].

Varanauskiene E, Varanauskaite I, Ceponis J.

Medicina (Kaunas). 2006;42(9):770-9. Review. Lithuanian.

10.

Spotlight on insulin aspart in type 1 and 2 diabetes mellitus.

Chapman TM, Noble S, Goa KL.

Treat Endocrinol. 2003;2(1):71-6. Review.

PMID:
15871555
11.

Insulin during pregnancy, labour and delivery.

de Valk HW, Visser GH.

Best Pract Res Clin Obstet Gynaecol. 2011 Feb;25(1):65-76. doi: 10.1016/j.bpobgyn.2010.10.002. Epub 2010 Dec 24. Review.

PMID:
21186142
12.

[Long-acting insulins in the treatment of type 2 diabetes: a hard choice].

Liebl A.

MMW Fortschr Med. 2015 Apr 16;157(7):65-8. doi: 10.1007/s15006-015-2977-6. Review. German. No abstract available.

PMID:
26012462
13.

Insulin detemir: a review of its use in the management of diabetes mellitus.

Keating GM.

Drugs. 2012 Dec 3;72(17):2255-87. doi: 10.2165/11470200-000000000-00000. Review.

PMID:
23110609
14.

Clinical efficacy and safety of insulin aspart compared with regular human insulin in patients with type 1 and type 2 diabetes: a systematic review and meta-analysis.

Wojciechowski P, Niemczyk-Szechowska P, Olewińska E, Jaros P, Mierzejewska B, Skarżyńska-Duk J, Małecki MT, Ryś P.

Pol Arch Med Wewn. 2015;125(3):141-51. Epub 2015 Jan 30. Review. Erratum in: Pol Arch Med Wewn. 2015;125(4):308.

15.

Comparing dosing of basal insulin analogues detemir and glargine: is it really unit-per-unit and dose-per-dose?

Wallace JP, Wallace JL, McFarland MS.

Ann Pharmacother. 2014 Mar;48(3):361-8. doi: 10.1177/1060028013518420. Epub 2014 Jan 6. Review.

PMID:
24396092

Supplemental Content

Support Center